# Phase II Lung Metcore - Preoperative Metformin for Lung Cancer

> **NCT03086733** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 28 (actual)

## Conditions studied

- Non Small Cell Lung Cancer
- Lung Cancer

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT03086733
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-05
- **Primary completion:** 2020-07
- **Final completion:** 2020-08
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2020-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03086733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03086733, "Phase II Lung Metcore - Preoperative Metformin for Lung Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03086733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*